Computed tomography coronary angiography in non-ST-segment elevation myocardial infarction

Area of Science:

• Cardiology
• Medical Imaging
• Diagnostic Technologies

Background:

• Standard evaluation for non-ST-segment elevation myocardial infarction (NSTEMI) involves electrocardiography and troponin testing, followed by invasive angiography.
• Current diagnostic pathways for NSTEMI can present challenges in diagnosis, management, and patient outcomes.
• Computed tomography coronary angiography (CTCA) is emerging as a valuable tool in the assessment of suspected NSTEMI.

Purpose of the Study:

• To review the current evidence on the clinical application of CTCA in patients with suspected or diagnosed NSTEMI.
• To highlight the role of CTCA in optimizing the diagnostic and management pathway for NSTEMI.
• To identify areas where CTCA may expand its impact on patient care and outcomes.

Main Methods:

• Review of existing clinical evidence and studies on the utilization of CTCA in NSTEMI patients.
• Analysis of CTCA's performance in guiding invasive coronary angiography and reducing non-invasive functional testing.
• Examination of CTCA's utility in identifying myocardial infarction with no obstructive coronary artery disease (MINOCA) and alternative diagnoses.

Main Results:

• CTCA demonstrates significant value in avoiding unnecessary invasive coronary angiography and reducing downstream testing for myocardial ischemia.
• CTCA provides crucial complementary information for patients with MINOCA and aids in diagnosing other causes of troponin elevation.
• The impact of routine CTCA application on major adverse cardiovascular events has not yet been conclusively demonstrated.

Conclusions:

• CTCA serves as an effective gatekeeper for the cardiac catheterization laboratory in the context of NSTEMI.
• Ongoing research into CTCA and related technologies is expected to further define and potentially broaden its clinical applications in NSTEMI.
• CTCA is poised to play an increasingly important role in the diagnosis and management of patients with NSTEMI.